Articles by Kelly A. Hoffman - BioPharm International

ADVERTISEMENT

ADVERTISEMENT
Articles by Kelly A. Hoffman

Final Word: Omnitrope's Approval: What Does It Mean For Other Generics?

FDA remains hesitant to open new avenues of approval for generic biologics
Aug 1, 2006
By: Nathan A. Beaver, Kelly A. Hoffman

Congress is not considering legislation that would expand FDA authority to regulate biologics.

ADVERTISEMENT

ADVERTISEMENT
Click here